2019 Webinar: HCC Staging and Treatments-HCC Staging and Treatments

Video Transcription

Video Summary

In this webinar, Vicki Shaw discusses the staging and treatment options for hepatocellular carcinoma (HCC). She covers the Barcelona Clinic Liver Cancer Staging System and the treatment recommendations according to the stages. She also explains the curative options such as liver transplantation, resection, and ablative therapies. Vicki further discusses the non-curative therapies including systemic chemotherapy, which is a significant part of the lecture. She mentions multikinase inhibitors like sorafenib and lenvatinib, which target tumor cells directly by inhibiting proliferation and angiogenesis. She also discusses immune therapies like nivolumab, which target the body's adaptive immune system. Vicki goes on to present the results of several clinical trials for new treatment options like regorafenib, cabozantinib, and pembrolizumab. She also discusses the limitations and potential side effects of these medications. In conclusion, Vicki highlights the importance of individualized treatment plans and ongoing research in the field of HCC.

Asset Caption

Presenter: Vicki Shah, PA-C, MMS
Moderator: HoChong Gilles, DNP, FNP-C

Keywords

hepatocellular carcinoma

Barcelona Clinic Liver Cancer Staging System

curative options

systemic chemotherapy

multikinase inhibitors

immune therapies

clinical trials

individualized treatment plans